Published on
July 29, 2019
- 11:18 GMT
uniQure Announces Second Quarter 2019 Results and Highlights Recent Company Progress
~ Presented 36 Weeks of Follow-up Data from Phase IIb Study of AMT-061 Demonstrating Sustained Increases in FIX Activity at up to 54% of Normal ~ ~ Continuing Patient Recruitment in HOPE-B Pivotal Study of AMT-061, With Completion of Enrollment Expected …
Distribution channels:
Business & Economy, Media, Advertising & PR
...
